Skip to content
DNA IRBM

CHDI Foundation extends collaboration with IRBM to accelerate development of Huntington’s disease therapeutics

19th November 2018, Pomezia, Italy – IRBM, a global contract research organization (CRO), has strengthened its position in neurodegenerative disease research following an extension of its long-standing collaboration with CHDI Foundation, a nonprofit biomedical research organization exclusively dedicated to collaboratively developing therapeutics that substantially improve the lives of those affected by Huntington’s disease (HD).

IRBM IN THE NEWS

PRESS RELEASES

EVENTS

Back To Top